Von Willebrand factor and oxidative stress parameters in acute coronary syndromes

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2011, Pages

  Jakovljevic, Vladimir ^b   Koprivica, Zoran ^a   Djordjevic, Dusica ^b   Vuletic, Milena ^b   Zivkovic, Vladimir ^b   Barudzic, Nevena ^b   Andjelkovic, Nebojsa ^b   Djuric, Dragan ^c   Iric Cupic, Violeta ^b   Krkeljic, Jelena ^b  

^a Health Centre   (Serbia)

^b UNIVERSITY OF KRAGUJEVAC   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROMES; ANTIOXIDANT DEFENCE; ANTIOXIDANT SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; HEALTHY CONTROLS; HIGH SPECIFICITY; LIPID PEROXIDATION; LOGISTIC REGRESSIONS; STRESS PARAMETER; SUPEROXIDE ANION RADICALS; SUPEROXIDE DISMUTASES; THERAPEUTIC TARGETS; THIOBARBITURIC ACID; VON WILLEBRAND FACTOR;

HYDROGEN; HYDROGEN PEROXIDE; NITRIC ACID; NITRIC OXIDE; NITROGEN OXIDES; OXIDATION; OXYGEN;

OXIDATIVE STRESS;

CATALASE; HYDROGEN PEROXIDE; NITRIC OXIDE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR ANTIGEN; GLUTATHIONE PEROXIDASE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OXIDATIVE STRESS; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ACUTE CORONARY SYNDROME; AGED; CATALASE; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HYDROGEN PEROXIDE; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VON WILLEBRAND FACTOR;

EID: 84860154464     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2011/918312     Document Type: Article

References (58)

1. Spiel A. O., Gilbert J. C., Jilma B., von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes Circulation 2008 117 11 1449 1459 (Pubitemid 351501497)
2. Derhaschnig U., Jilma B., Assessment of platelets and the endothelium in patients presenting with acute coronary syndromesis there a future? Thrombosis and Haemostasis 2009 102 6 1144 1148
3. Blann A., von Willebrand factor and the endothelium in vascular disease British Journal of Biomedical Science 1993 50 2 125 134 (Pubitemid 23316848)
4. Lip G. Y., Blann A., von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovascular Research 1997 34 2 255 265 (Pubitemid 27241568)
5. Vischer U. M., von Willebrand factor, endothelial dysfunction, and cardiovascular disease Journal of Thrombosis and Haemostasis 2006 4 6 1186 1193
6. Folsom A. R., Wu K. K., Rosamond W. D., Sharrett A. R., Chambless L. E., Prospective study of hemostatic factors and incidence of coronary heart disease: the atherosclerosis risk in communities (ARIC) study Circulation 1997 96 4 1102 1108 (Pubitemid 27344210)
7. Rumley A., Lowe G. D., Sweetnam P. M., Yarnell J. W., Ford R. P., Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the caerphilly heart study British Journal of Haematology 1999 105 1 110 116 (Pubitemid 29197151)
8. Morange P. E., Simon C., Alessi M. C., Luc G., Arveiler D., Ferrieres J., Amouyel P., Evans A., Ducimetiere P., Juhan-Vague I., Endothelial cell markers and the risk of coronary heart disease: the prospective epidemiological study of myocardial infarction (PRIME) study Circulation 2004 109 11 1343 1348 (Pubitemid 38387818)
9. Whincup P. H., Danesh J., Walker M., Lennon L., Thomson A., Appleby P., Rumley A., Lowe G. D. O., von Willebrand factor and coronary heart disease: prospective study and meta-analysis European Heart Journal 2002 23 22 1764 1770 (Pubitemid 35334269)
10. Lee K. W., Lip G. Y., Tayebjee M., Foster W., Blann A. D., Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes Blood 2005 105 2 526 532 (Pubitemid 40070731)
11. Sakai H., Goto S., Kim J. Y., Aoki N., Abe S., Ichikawa N., Yoshida M., Nagaoka Y., Handa S., Plasma concentration of von Willebrand factor in acute myocardial infarction Thrombosis and Haemostasis 2000 84 2 204 209 (Pubitemid 30601464)
12. Jansson J. H., Nilsson T. K., Johnson O., von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death British Heart Journal 1991 66 5 351 355
13. Wiman B., Andersson T., Hallqvist J., Reuterwall C., Ahlbom A., de Faire U., Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the stockholm heart epidemiology program (SHEEP) study Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 8 2019 2023 (Pubitemid 30644653)
14. Fuchs I., Frossard M., Spiel A., Riedmuller E., Laggner A. N., Jilma B., Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS Journal of Thrombosis and Haemostasis 2006 4 2547 2552 (Pubitemid 44741545)
15. Vischer U. M., de Moerloose P., von Willebrand factor: from cell biology to the clinical management of von Willebrand's disease Critical Reviews in Oncology/Hematology 1999 30 2 93 109 (Pubitemid 29232248)
16. Paulinska P., Spiel A., Jilma B., Role of von Willebrand factor in vascular disease Hamostaseologie 2009 29 1 32 38
17. Vischer U. M., Jornot L., Wollheim C. B., Theler J. M., Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells Blood 1995 85 11 3164 3172
18. Matsushita K., Morrell C. N., Mason R. J. A., Yamakuchi M., Khanday F. A., Irani K., Lowenstein C. J., Hydrogen peroxide regulation of endothelial exocytosis by inhibition of N-ethylmaleimide sensitive factor Journal of Cell Biology 2005 170 1 73 79 (Pubitemid 40994097)
19. Yang S. X., Yan J., Deshpande S. S., Irani K., Lowenstein C. J., Rac1 regulates the release of Weibel-Palade bodies in human aortic endothelial cells Chinese Medical Journal 2004 117 8 1143 1150 (Pubitemid 39199917)
20. Valgimigli M., Merli E., Malagutti P., Soukhomovskaia O., Cicchitelli G., Macr G., Ferrari R., Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress Archives of Biochemistry and Biophysics 2003 420 2 255 261 (Pubitemid 37491109)
21. Dhalla N. S., Temsah R. M., Netticadan T., Role of oxidative stress in cardiovascular diseases Journal of Hypertension 2000 18 6 655 673 (Pubitemid 30406736)
22. Kojda G., Harrison D., Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure Cardiovascular Research 1999 43 3 562 571 (Pubitemid 29369255)
23. Elahi M. M., Kong Y. X., Matata B. M., Oxidative stress as a mediator of cardiovascular disease Oxidative Medicine and Cellular Longevity 2009 2 5 259 269
24. Maiese K., Marking the onset of oxidative stress: biomarkers and novel strategies Oxidative Medicine and Cellular Longevity 2009 2 1 1
25. Moe K. T., Wong P., Current trends in diagnostic biomarkers of acute coronary syndrome Annals of the Academy of Medicine Singapore 2010 39 3 210 215
26. Bonaca M. P., Morrow D. A., Defining a role for novel biomarkers in acute coronary syndromes Clinical Chemistry 2008 54 9 1424 1431
27. Anderson J. L., Adams C. D., Antman E. M., Bridges C. R., Califf R. M., Casey D. E., Chavey W. E., Fesmire F. M., Hochman J. S., Levin T. N., Lincoff A. M., Peterson E. D., Theroux P., Wenger N. K., Wright R. S., Smith S. C., Jacobs A. K., Adams C. D., Anderson J. L., Antman E. M., Halperin J. L., Hunt S. A., Krumholz H. M., Kushner F. G., Lytle B. W., Nishimura R., Ornato J. P., Page R. L., Riegel B., ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Journal of the American College of Cardiology 2007 50 7 e1 e157
28. Armstrong E. J., Morrow D. A., Sabatine M. S., Inflammatory biomarkers in acute coronary syndromespart II. Acute-phase reactants and biomarkers of endothelial cell activation Circulation 2006 113 7 e152 e155
29. Armstrong E. J., Morrow D. A., Sabatine M. S., Inflammatory biomarkers in acute coronary syndromespart IV. Matrix metalloproteinases and biomarkers of platelet activation Circulation 2006 113 9 e382 e385
30. Biasucci L. M., CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper Circulation 2004 110 25 e560 e567
31. Hurks R., Peeters W., Derksen W. J., Hellings W. E., Hoefer I. E., Moll F. L., de Kleijn D. P. V., Pasterkamp G., Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease Thrombosis and Haemostasis 2009 101 1 48 54
32. Favaloro E. J., Laboratory identification of von Willebrand disease: technical and scientific perspectives Seminars in Thrombosis and Hemostasis 2006 32 5 456 471 (Pubitemid 44157383)
33. Lee K. W., Blann A. D., Lip G. Y., Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes International Journal of Cardiology 2006 111 2 302 308 (Pubitemid 44107573)
34. Yazdani S., Simon A. D., Kovar L., Wang W., Schwartz A., Rabbani L. E., Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina Journal of the American College of Cardiology 1997 30 5 1284 1287 (Pubitemid 27501447)
35. Eto K., Isshiki T., Yamamoto H., Takeshita S., Ochiai M., Yokoyama N., Yoshimoto R., Ikeda Y., Sato T., AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 4 877 882 (Pubitemid 29177332)
36. Vaziri N. D., Kennedy S. C., Kennedy D., Gonzales E., Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris American Journal of Medicine 1992 93 6 651 657
37. Frossard M., Fuchs I., Leitner J. M., Hsieh K., Vlcek M., Losert H., Domanovits H., Schreiber W., Laggner A. N., Jilma B., Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 2004 110 11 1392 1397 (Pubitemid 39238016)
38. Thogersen A. M., Jansson J. H., Boman K., Nilsson T. K., Weinehall L., Huhtasaari F., Hallmans G., High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor Circulation 1998 98 21 2241 2247 (Pubitemid 28533841)
39. Danesh J., Wheeler J. G., Hirschfield G. M., Eda S., Eiriksdottir G., Rumley A., Lowe G. D. O., Pepys M. B., Gudnason V., C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease New England Journal of Medicine 2004 350 14 1387 1397 (Pubitemid 38419992)
40. Thompson S. G., Kienast J., Pyke S. D., Haverkate F., van de Loo J. C., Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: european concerted action on thrombosis and disabilities angina pectoris study group The New England Journal of Medicine 1995 332 635 641
41. Jansson J. H., Nilsson T. K., Johnson O., von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death British Heart Journal 1991 66 5 351 355
42. Cortellaro M., Boschetti C., Cofrancesco E., Zanussi C., Catalano M., de Gaetano G., The PLAT study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: principal results: PLAT study group: Progetto Lombardo Atero-Trombosi (PLAT) study group Arteriosclerosis, Thrombosis, and Vascular Biology 1992 12 1063 1070
43. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A., Biomarkers of oxidative damage in human disease Clinical Chemistry 2006 52 4 601 623
44. Pandey K. B., Rizvi S. I., Markers of oxidative stress in erythrocytes and plasma during aging in humans Oxidative Medicine and Cellular Longevity 2010 3 1 2 12
45. Reddy V. P., Beyaz A., Perry G., Cooke M. S., Sayre L. M., Smith M. A., The role of oxidative damage to nucleic acids in the pathogenesis of neurological disease Oxidative Medicine and Cellular Longevity 2005 1 6 535 544
46. Gomes P., Simo S., Silva E., Pinto V., Amaral J. S., Afonso J., Serro M. P., Pinho M. J., Soares-Da-Silva P., Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure Oxidative Medicine and Cellular Longevity 2009 2 3 138 145
47. Jilma B., Pernerstorfer T., Dirnberger E., Stohlawetz P., Schmetterer L., Singer E. A., Grasseli U., Eichler H. G., Kapiotis S., Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigen Journal of Laboratory and Clinical Medicine 1998 131 2 151 156 (Pubitemid 28107155)
48. Pernerstorfer T., Stohlawetz P., Kapiotis S., Eichler H. G., Jilma B., Partial inhibition of nitric oxide synthase primes the stimulated pathway of VWF-secretion in man Atherosclerosis 2000 148 1 43 47
49. Kumar A., Cannon C. P., Acute coronary syndromes: diagnosis and managementpart I Mayo Clinic Proceedings 2009 84 10 917 938
50. Alpert J. S., Thygesen K., Antman E., Bassand J. P., Myocardial infarction redefineda consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction Journal of the American College of Cardiology 2000 36 959 969
51. Green L. C., Wagner D. A., Glogowski J., Skipper P. L., Wishnok J. S., Tannenbaum S. R., Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids Analytical Biochemistry 1982 126 1 131 138 (Pubitemid 13203451)
52. Auclair C., Voisin E., Greenvvald R. A., Nitroblue tetrazolium reduction Handbook of Methods for Oxygen Radical Research 1985 Boka Raton, Fla, USA CRC Press 123 132
53. Pick E., Keisari Y. A., A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture Journal of Immunological Methods 1980 38 1-2 161 170 (Pubitemid 11251411)
54. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Analytical Biochemistry 1979 95 2 351 358 (Pubitemid 9194347)
55. McCord J. M., Fridovich I., The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen Journal of Biological Chemistry 1969 244 22 6056 6063
56. Beutler E., Beutler E., Catalase Red Cell Metabolism, A Manual of Biochemical Methods 1982 New York, NY, USA Grune and Stratton 105 106
57. Tsuchihashi M., Zur Kernntnis der blutkatalase Biochemische Zeitschrift 1923 140 65 72
58. Misra H. P., Fridovich I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase Journal of Biological Chemistry 1972 247 10 3170 3175